Suchergebnisse - "Duan, Zhenfeng"

PubPharm (32)

1

SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma

enthalten in: Bioscience reports | 2022

von Guo, T. | Wei, R. | Dean, D. | +2

RetractionIn: Biosci Rep. 2023 Nov 30;43(11):. - PMID 37921048

2

Expression and clinical implications of leucine-rich repeat containing 15 (LRRC15) in osteosarcoma

enthalten in: Journal of orthopaedic research : official publication of the Orthopaedic Research Society | 2020

von Cui, J. | Dean, D. | Wei, R. | +3

3

Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma

enthalten in: Journal of orthopaedic research : official publication of the Orthopaedic Research Society | 2020

von Wei, R. | Thanindratarn, P. | Dean, D. | +3

4

Cancer testis antigens in sarcoma : Expression, function and immunotherapeutic application

enthalten in: Cancer letters | 2020

von Wei, R. | Dean, D. | Thanindratarn, P. | +3

5

Establishment and Characterization of a Recurrent Osteosarcoma Cell Line : OSA 1777

enthalten in: Journal of orthopaedic research : official publication of the Orthopaedic Research Society | 2020

von Thanindratarn, P. | Li, X. | Dean, D. | +3

ErratumIn: J Orthop Res. 2023 Nov 28;:. - PMID 38014856

6

Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy

enthalten in: Cancer letters | 2020

von Zhao, J. | Dean, D. | Hornicek, F. | +2

7

MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma

enthalten in: Scientific reports | 2020

von Lietz, C. | Garbutt, C. | Barry, W. | +14

8

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2019

von Wang, J. | Dean, D. | Hornicek, F. | +2

9

RNA sequencing (RNA-Seq) and its application in ovarian cancer

enthalten in: Gynecologic oncology | 2019

von Wang, J. | Dean, D. | Hornicek, F. | +2

10

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma

enthalten in: EBioMedicine | 2019

von Ma, H. | Seebacher, N. | Hornicek, F. | +1